Best Practices, LLC Home
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Sales and Marketing > New Product Development and Launch > Planning and Coordinating Launch > Development Activities

Development Activities Research

New Product Launch Spend: What It Takes To Win In The U.S. Market 
In today’s pharmaceutical industry–where the recent product launch landscape is marked by as many failures as successes—it is critical for launch teams to understand the right level of resources required to give each new product its best chance for gaining a market foothold... (ID PSM-262)
Companies Profiled: Abbott, ProStrakan, Sanofi-aventis, Regeneron, more ...
Price: $8000.00   Free Excerpt Available


Pharmaceutical New Product Commercialization: Preparing for Market Success 
Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value... (ID SM-176)
Companies Profiled: Abbott, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $7795.00   Free Excerpt Available


Best Practices in New Product Commercialization 
Non-members: Click here for a complimentary excerpt of Best Practices in New Product Commercialization... (ID 5001)
Companies Profiled: Abbott, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $4995.00   Free Excerpt Available


Pharmaceutical New Product Commercialization: Preparing for Market Success 
Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value... (ID PSM-227)
Companies Profiled: Abbott, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $4595.00   Free Excerpt Available


Pharmaceutical Product Launch Evaluation Excellence: Processes & Measures to Evaluate Launch Success 
In this highly competitive and scrutinized marketplace, pharmaceutical and biotech companies have continuously examined the product launch process to cut costs and to increase performance... (ID PSM-230)
Companies Profiled: Medtronic, Sanofi-aventis, Organon, Teva Pharmaceutical Industries Ltd, more ...
Price: $4500.00   Free Excerpt Available


Pharmaceutical Product Launch Evaluation Excellence: Processes & Measures to Evaluate Launch Success 
Non-members: Click here to download a complimentary excerpt of "Pharmaceutical Product Launch Evaluation Excellence: Processes & Measures to Evaluate Launch Success" STUDY OVERVIEW In this highly competitive and scrutinized marketplace, pharmaceutical and biotech companies have continuously examined the product launch process to cut costs and to increase performance... (ID 5011)
Companies Profiled: Medtronic, Organon, Myriad, Teva Pharmaceutical Industries Ltd, more ...
Price: $4500.00   Free Excerpt Available


Winning the Hearts and Minds of Preferred Clinical Investigators 
Study Overview Attracting preferred investigators and winning their participation in clinical trials requires careful planning and execution by study sponsors... (ID 4620)
Companies Profiled: AAI Development, Amgen, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, more ...
Price: $2348.95


Selecting Effective and Productive Investigators for Clinical Trials 
Study Overview Selecting top-notch clinical investigators is the most crucial step in the clinical trial process... (ID 4623)
Companies Profiled: AAI Development, Amgen, AstraZeneca, Bristol-Myers Squibb, more ...
Price: $1748.95


Effectiveness of Pharmaceutical Lifecycle Management Tactics 
Study Overview This survey-based benchmarking exchange was designed to understand how companies can extend and optimize the value of pharmaceutical products as they enter the late mature phase of the product life cycle... (ID 4864)
Companies Profiled: Abbott Laboratories, Solvay America, Sanofi-Synthelabo Inc., Pfizer, more ...
Price: $1320.00


Commercializing New Products, Allocating Resources, and Managing the Product Life Cycle 
Study Overview Top companies find that developing yearly business plans for all products in the development pipeline allow companies to budget all resources, thereby reducing waste and idle resources... (ID 4682)
Companies Profiled: Eli Lilly, Pfizer, Amgen, Janssen
Price: $1278.95


Setting and Measuring Clear Goals for Medical Programs 
Study Overview Constant reevaluation and improvement is the key to a successful medical program... (ID 4646)
Companies Profiled: AstraZeneca, Sanofi-aventis, Merck, Schering-Plough, more ...
Price: $915.00


Managing Cross-Functional Pharmaceutical Launch Teams 
Leading pharmaceutical companies have learned that team management is a complex process... (ID 4568)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline , more ...
Price: $823.95


Market Research for Pharmaceutical Launches 
As the market for pharmaceutical products grows, top-performing pharmaceutical companies must involve marketing as early as possible to achieve worldwide appeal... (ID 4571)
Companies Profiled: Sanofi-aventis, Merck, Eli Lilly, GlaxoSmithKline , more ...
Price: $817.95


Global Marketing Launch Strategy & Structure 
In today’s crowded marketplace, pharmaceutical companies must develop a strategy that supports business objectives and forms an effective launch team for their product to achieve attention... (ID 4567)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline , more ...
Price: $812.95


Timing, Structuring and Staffing for Drug Delivery System Development 
Study Overview As there are more me-too drugs crowding the marketplace, it is becoming critical to differentiate products through new formulations and delivery methods... (ID 4782)
Companies Profiled: Amgen, Vital Therapies, Bayer, Theratechnologies, more ...
Price: $795.00


Marketing Activities in Phase III 
The single-page document includes graphs showing what activities 12 leading pharmaceutical companies conduct during Phase III... (ID 4098)
Companies Profiled: Leading Pharmaceutical Companies
Price: $74.95


Marketing Activities in Phase II 
The single-page document includes graphs showing what activities 12 leading pharmaceutical companies conduct during Phase II... (ID 4097)
Companies Profiled: Leading Pharmaceutical Companies
Price: $74.95


Marketing Activities in Phase I 
The single-page document includes graphs showing what activities 12 leading pharmaceutical companies conduct during Phase I... (ID 4096)
Companies Profiled: Leading Pharmaceutical Companies
Price: $74.95


Marketing Activities in the Pre-Clinical Phase 
The single-page document includes graphs showing what activities 12 leading pharmaceutical companies conduct during the Pre-Clinical Phase... (ID 4095)
Companies Profiled: Leading Pharmaceutical Companies
Price: $74.95


Timing of Dedicated Marketing Personnel 
The single-page document includes a graph showing when 12 leading pharmaceutical companies first assign a marketing individual to support a product compound at the global or country unit level... (ID 4094)
Companies Profiled: Leading Pharmaceutical Companies
Price: $74.95


 


All contents copyright 1996--2012 Best Practices, LLC (919) 403-0251
Site Map | Read our Terms and Conditions of Use, Privacy Policy and Copyright Information.